Trend is changing in Pharma industry after 3-4 years of slump condition. Note that Cipla is a very volatile stock. At present price has recovered from lows and is facing resistance. So this is a decisive level. Price is comfortable above 200 DMA and one more thing is 50 DMA may soon cross 100 DMA which will boost the sentiment. A correction or consolidation is expected at the present level.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.